{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Indiana",
      "state": "PA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "91980",
      "recalling_firm": "RemedyRepack Inc.",
      "address_1": "625 Kolter Dr Ste 4",
      "address_2": "",
      "postal_code": "15701-3571",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "RemedyRepack distributed product to consignees nationwide within the United States",
      "recall_number": "D-0499-2023",
      "product_description": "Ropinirole 2mg tablets, packaged in 180-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC70518-2750-00",
      "product_quantity": "3 bottles",
      "reason_for_recall": "cGMP Deviations",
      "recall_initiation_date": "20230320",
      "center_classification_date": "20230331",
      "termination_date": "20231019",
      "report_date": "20230412",
      "code_info": "Lot#: B1630017-040122, Exp. Date 04/30/2023",
      "more_code_info": ""
    }
  ]
}